MAAT INDEX

CLAIM #47201 · ORCL (ORCL) · 2023Q2 earnings call · Dec 12, 2022 · due Dec 12, 2024

But ultimately, just so that you understand, our expectation is we will run them at typical Oracle margins.

Safra Catz · CEO

PENDING
graded after results covering Dec 12, 2024 are reported

In context

on, and congratulations on the quarter. Two related questions on Cerner. Safra, where are we on the Cerna integration process as well as taking out the cost? And where do you think you can drive those long-term costs over time. And Larry, we heard a lot of great features at Oracle World about Cerner and what you going to do in healthcare. It’d be interesting to hear what progress you’ve made recently. Thanks. Safra Catz: Sure. So Mark, we’ve owned Cerner for about five months. And I will tell you that they continue to do better than we had projected internally. So, we’re very, very happy. But we are still at the beginning. We don’t want to do anything that will damage the business. And of course, we’re very, very focused on those customers. But we are already having some level of savings. But ultimately, just so that you understand, our expectation is we will run them at typical Oracle margins. So, we’ve got quite a way to go. And I think over the next couple of quarters, you’ll see continued improvement as we’ve done some of our operational integration. And simultaneously, I think they continue to over perform for us. So, we are doing this in a very careful way. So, it’s not to put any issues for our customers and making sure they’re successful. On the technical side, Larry, that’s for you. Larry Ellison: Yes. Well, actually, on the technical side, of course, what we’re trying to do is build -- not just provider systems. In other words, what Cerner did primarily in competition with EPIC is the automated hospitals. And yes, we want to automate hospitals and clinics and doctors’ offices and do that. We certainly want to automate providers. But we’re layering on top of that is we

Verify independently

SEC filings for ORCL · Claim quote is verbatim from the 2023Q2 earnings call.